{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/RGNX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T09:02:10.998Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3928,"canonical_name":"REGENXBIO Inc.","cik":"0001590877","uei":null,"lei":null,"duns":null,"ticker":"RGNX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":52,"clinical":2},"count":54,"timeline":[{"ts":"2026-10-16","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-10-16","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-423376","accession_number":"0001193125-26-423376","importance":35},{"ts":"2026-10-13","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — REGENXBIO Inc. — 2026-10-13","url_slug":"/sec/cik-0001590877/schedule-13g/0000019617-26-000350","accession_number":"0000019617-26-000350","importance":55},{"ts":"2026-09-23","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-09-23","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-399377","accession_number":"0001193125-26-399377","importance":35},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-09-03","url_slug":"/sec/cik-0001590877/4/0001789335-26-000008","accession_number":"0001789335-26-000008","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-09-03","url_slug":"/sec/cik-0001590877/4/0002062007-26-000005","accession_number":"0002062007-26-000005","importance":30},{"ts":"2026-08-27","kind":"sec.filing","form_type":"3","title":"3 — REGENXBIO Inc. — 2026-08-27","url_slug":"/sec/cik-0001590877/3/0002023732-26-000007","accession_number":"0002023732-26-000007","importance":30},{"ts":"2026-08-27","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-08-27","url_slug":"/sec/cik-0001590877/4/0002023732-26-000008","accession_number":"0002023732-26-000008","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-08-25","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-365287","accession_number":"0001193125-26-365287","importance":35},{"ts":"2026-08-24","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-08-24","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-363786","accession_number":"0001193125-26-363786","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — REGENXBIO Inc. — 2026-08-06","url_slug":"/sec/cik-0001590877/10-q/0001193125-26-336725","accession_number":"0001193125-26-336725","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-08-06","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-336716","accession_number":"0001193125-26-336716","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-08-04","url_slug":"/sec/cik-0001590877/4/0001700659-26-000016","accession_number":"0001700659-26-000016","importance":30},{"ts":"2026-08-01","kind":"sec.insider.f","reporter":"PAKOLA STEVE","title":"Chief Medical Officer","shares":7468,"price_per_share":9.69,"usd_value":72365,"security_title":"Common Stock","importance":15.07236492},{"ts":"2026-08-01","kind":"sec.insider.f","reporter":"Christmas Patrick J.","title":"Chief Strategy & Legal Officer","shares":4699,"price_per_share":9.69,"usd_value":45533,"security_title":"Common Stock","importance":15.04553331},{"ts":"2026-07-20","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-07-20","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-308342","accession_number":"0001193125-26-308342","importance":35},{"ts":"2026-07-17","kind":"sec.filing","form_type":"424B5","title":"424B5 — REGENXBIO Inc. — 2026-07-17","url_slug":"/sec/cik-0001590877/424b5/0001193125-26-308027","accession_number":"0001193125-26-308027","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"FWP","title":"FWP — REGENXBIO Inc. — 2026-07-17","url_slug":"/sec/cik-0001590877/fwp/0001193125-26-306576","accession_number":"0001193125-26-306576","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"424B5","title":"424B5 — REGENXBIO Inc. — 2026-07-16","url_slug":"/sec/cik-0001590877/424b5/0001193125-26-306170","accession_number":"0001193125-26-306170","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-07-06","url_slug":"/sec/cik-0001590877/4/0001700659-26-000014","accession_number":"0001700659-26-000014","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"SC TO-I/A","title":"SC TO-I/A — REGENXBIO Inc. — 2026-07-06","url_slug":"/sec/cik-0001590877/sc-to-i-a/0001193125-26-295587","accession_number":"0001193125-26-295587","importance":30},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"PAKOLA STEVE","title":"Chief Medical Officer","shares":2161,"price_per_share":13.64,"usd_value":29476,"security_title":"Common Stock","importance":35.02947604},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"PAKOLA STEVE","title":"Chief Medical Officer","shares":2161,"price_per_share":7.86,"usd_value":16985,"security_title":"Common Stock","importance":15.01698546},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"PAKOLA STEVE","title":"Chief Medical Officer","shares":36725,"price_per_share":12.86,"usd_value":472284,"security_title":"Common Stock","importance":35.4722835},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — REGENXBIO Inc. — 2026-07-01","url_slug":"/sec/cik-0001590877/144/0001950047-26-006719","accession_number":"0001950047-26-006719","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-07-01","url_slug":"/sec/cik-0001590877/4/0001700659-26-000012","accession_number":"0001700659-26-000012","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"SC TO-I/A","title":"SC TO-I/A — REGENXBIO Inc. — 2026-07-01","url_slug":"/sec/cik-0001590877/sc-to-i-a/0001193125-26-291681","accession_number":"0001193125-26-291681","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"PAKOLA STEVE","title":"Chief Medical Officer","shares":36725,"price_per_share":7.86,"usd_value":288659,"security_title":"Common Stock","importance":15.2886585},{"ts":"2026-07-01","kind":"sec.insider.f","reporter":"Simpson Curran","title":"Chief Executive Officer","shares":6818,"price_per_share":13.09,"usd_value":89248,"security_title":"Common Stock","importance":15.08924762},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Simpson Curran","title":"Chief Executive Officer","shares":1453,"price_per_share":10.18,"usd_value":14792,"security_title":"Common Stock","importance":15.01479154},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"PAKOLA STEVE","title":"Chief Medical Officer","shares":19608,"price_per_share":11.04,"usd_value":216472,"security_title":"Common Stock","importance":35.21647232},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-06-29","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-286825","accession_number":"0001193125-26-286825","importance":35},{"ts":"2026-06-17","kind":"clinical.trial","reporter":"REGENXBIO Inc.","title":"Expanded Access to RGX-202","security_title":null,"status":"TEMPORARILY_NOT_AVAILABLE","accession_number":"NCT07652606","excerpt":null,"importance":25},{"ts":"2026-06-04","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — REGENXBIO Inc. — 2026-06-04","url_slug":"/sec/cik-0001590877/schedule-13g-a/0000019617-26-000236","accession_number":"0000019617-26-000236","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-06-03","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-254590","accession_number":"0001193125-26-254590","importance":35},{"ts":"2026-06-03","kind":"sec.filing","form_type":"SC TO-I","title":"SC TO-I — REGENXBIO Inc. — 2026-06-03","url_slug":"/sec/cik-0001590877/sc-to-i/0001193125-26-254638","accession_number":"0001193125-26-254638","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-06-02","url_slug":"/sec/cik-0001590877/4/0001652824-26-000003","accession_number":"0001652824-26-000003","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-06-02","url_slug":"/sec/cik-0001590877/4/0001652936-26-000001","accession_number":"0001652936-26-000001","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-06-02","url_slug":"/sec/cik-0001590877/4/0001658390-26-000001","accession_number":"0001658390-26-000001","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-06-02","url_slug":"/sec/cik-0001590877/4/0001737231-26-000002","accession_number":"0001737231-26-000002","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-06-02","url_slug":"/sec/cik-0001590877/4/0001872219-26-000001","accession_number":"0001872219-26-000001","importance":30},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"MIGAUSKY GEORGE V","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"STUMP DAVID C","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"KARABELAS ARGERIS N","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Tasse Daniel","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Fox Allan M.","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Mills Kenneth T.","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Glucksmann Alexandra","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Zachary Jennifer","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Bennett Jean","title":"","shares":9807,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — REGENXBIO Inc. — 2026-05-14","url_slug":"/sec/cik-0001590877/10-q/0001193125-26-222804","accession_number":"0001193125-26-222804","importance":45},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — REGENXBIO Inc. — 2026-05-14","url_slug":"/sec/cik-0001590877/8-k/0001193125-26-222768","accession_number":"0001193125-26-222768","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"4","title":"4 — REGENXBIO Inc. — 2026-05-13","url_slug":"/sec/cik-0001590877/4/0001700659-26-000010","accession_number":"0001700659-26-000010","importance":30},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"PAKOLA STEVE","title":"Chief Medical Officer","shares":15309,"price_per_share":11.02,"usd_value":168705,"security_title":"Common Stock","importance":35.16870518},{"ts":"2026-04-29","kind":"clinical.trial","reporter":"REGENXBIO Inc.","title":"Long Term Follow-Up for RGX-111","security_title":null,"status":"ENROLLING_BY_INVITATION","accession_number":"NCT06103487","excerpt":"[\"Mucopolysaccharidosis I\"]","importance":25}]}